Agios stock nasdaq
AGIO Stock Price and Chart — NASDAQ:AGIO — TradingView Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. AGIO Agios Pharmaceuticals — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
AGIO | Complete Agios Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
FAQs | Agios Pharmaceuticals, Inc. Jul 24, 2013 · Where is Agios’ corporate headquarters located? Agios is headquartered at 88 Sidney Street, 2nd floor, Cambridge, MA 02139, U.S. The main phone number is (617) 649-8600. How is Agios’ stock traded? Agios is traded on the NASDAQ global stock exchange under the ticker symbol AGIO, and its CUSIP number for the common stock is 00847X 104. AGIO - Agios Pharmaceuticals Stock Interactive Chart ... Settings. Click the Settings icon to access different options for your chart.. DISPLAY Tab. Bar Type: For each Bar Type, you may customize the color and thickness of the bars. OHLC Bars are drawn to show the open-high-low-close. A vertical line is drawn between the highest and lowest price. The horizontal dash extending to the left of the bar represents the open, and the horizontal dash
View the latest Agios Pharmaceuticals Inc. (AGIO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
AGIO Stock Price and Chart — NASDAQ:AGIO — TradingView Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. AGIO Agios Pharmaceuticals — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. AGIO Stock Quote - Agios Pharmaceuticals, Inc. Common ...
AGIO's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low
Expensive Market, What To Buy? Agios Pharmaceuticals Inc ... Mar 12, 2020 · Barclays wasn’t the only research firm that published a report of Agios Pharmaceuticals Inc., with other equities research analysts also giving their opinion on the stock. Cantor Fitzgerald advised investors in its research note published on November 26, 2019, to Overweight the AGIO stock while also putting a $64 price target. NASDAQ Welcomes Agios Pharmaceuticals, Inc. to The NASDAQ ...
Agios Pharmaceuticals (NASDAQ:AGIO) Ratings | Benzinga
Agios Pharmaceuticals, Inc. Common Stock (AGIO ... - Nasdaq Agios Pharmaceuticals, Inc. Common Stock (AGIO) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. AGIO Stock Price | Agios Pharmaceuticals Inc. Stock Quote ...
AGIO: Agios Pharmaceuticals Inc - Stock Price ... - CNBC Get Agios Pharmaceuticals Inc (AGIO:NASDAQ) real-time stock quotes, news and financial information from CNBC.